Consistently, shRNA mediated silencing of Smad2, Smad3, or Smad4, or overexpression of inhibitory Smad7 (data not shown) led to accelerated HCC onset in c-Myc mice. Here, SMAD2 is linked to hepatocellular carcinoma.